PCSA - What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today? | Benzinga
Thursday, Processa Pharmaceuticals Inc (NASDAQ:PCSA) shares closed 148.8% higher at $5.10.
Friday, the company priced a public offering of 1.56 million shares (or pre-funded warrants in lieu thereof) and common warrants to purchase up to 1.56 million shares at a combined public offering price per share of common stock (or per pre-funded warrants in lieu thereof) and accompanying common warrant of $4.50.
The common warrants will have an exercise price of $4.50 per share. Gross proceeds to the company is expected to be $7.0 million.
The stock is trading lower on high volume, with a session volume of 4.37 ...